What question did this study set out to answer?

To review current evidence on the diagnosis, staging, prognosis, and evolving medical therapies for inflammatory bowel diseases.

December 19, 2025BMJ

Medical management of inflammatory bowel diseases

View Full Paper

Ask AI

Bookmark

Authors

JHJana G. Hashash JLJimmy K. Limdi JSJason M. Shapiro

Discussion

Member takes

Overview

Clinical review highlights targeted immunomodulatory treatments and mucosal healing targets in inflammatory bowel disease, indicating improved long-term patient prognosis and quality of life.

Key Points

To review current evidence on the diagnosis, staging, prognosis, and evolving medical therapies for inflammatory bowel diseases.
Synthesized recent literature on the pathophysiology, staging, and therapeutic interventions for Crohn's disease and ulcerative colitis.
Evaluated modern management strategies focusing on immune-modulating drugs and objective monitoring tools like colonoscopy and imaging.
Treatment paradigms have shifted from solely addressing clinical symptoms to targeting deep remission, defined as objective mucosal healing.
Achieving mucosal healing and patient-reported clinical remission substantially improves long-term disease prognosis and overall quality of life.
The global disease burden continues to grow, with prevalence expected to reach 1% in early industrialized nations over the next decade.

Cite This Study

Hashash et al. (2025) studied this question.

synapsesocial.com/papers/695d5132fb8fdf0c4c20caeb https://doi.org/10.1136/bmj-2025-079050

View Full Paper

Ask AI

Bookmark

December 19, 2025BMJ

Medical management of inflammatory bowel diseases

View Full Paper

Ask AI

Bookmark

Authors

JHJana G. Hashash JLJimmy K. Limdi JSJason M. Shapiro

Discussion

Member takes

Overview

Clinical review highlights targeted immunomodulatory treatments and mucosal healing targets in inflammatory bowel disease, indicating improved long-term patient prognosis and quality of life.

Key Points

To review current evidence on the diagnosis, staging, prognosis, and evolving medical therapies for inflammatory bowel diseases.
Synthesized recent literature on the pathophysiology, staging, and therapeutic interventions for Crohn's disease and ulcerative colitis.
Evaluated modern management strategies focusing on immune-modulating drugs and objective monitoring tools like colonoscopy and imaging.
Treatment paradigms have shifted from solely addressing clinical symptoms to targeting deep remission, defined as objective mucosal healing.
Achieving mucosal healing and patient-reported clinical remission substantially improves long-term disease prognosis and overall quality of life.
The global disease burden continues to grow, with prevalence expected to reach 1% in early industrialized nations over the next decade.

Cite This Study

Hashash et al. (2025) studied this question.

synapsesocial.com/papers/695d5132fb8fdf0c4c20caeb https://doi.org/10.1136/bmj-2025-079050

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark